A recent work reported a strategy to overcome drug resistance in cancer based on blocking P-glycoprotein (P-gp), an ATP-binding membrane protein involved in the cellular efflux of many drugs that is overexpressed in multi-drug resistant cancer cells [163]. The gene discussed is PGP; the disease is cancer.